2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Catalyst4, Inc. | 10% Owner | 6,678,910 | Oct 29, 2025 |
| Novo A/S | 10% Owner | 1,174,682 | Oct 30, 2025 |
| Foff Erin Pennock | Chief Medical Officer | 196,035 | Oct 28, 2025 |
| Setia Vishwas | CFO | 176,031 | Oct 28, 2025 |
| Kreitzer Anatol | Chief Discovery Officer | 146,052 | Oct 28, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Feb 24, 2026 | Malenka Robert C. | Director | Sell | 20.0 | -14,195 | -3.83% | ✗ | $260.4K |
| Feb 18, 2026 | Feb 20, 2026 | Pavlov George | Director | Buy | 97.5 | +25,000 | 100.00% | ✗ | $441.2K |
| Feb 13, 2026 | Feb 18, 2026 | Malenka Robert C. | Director | Sell | 22.5 | -12,116 | -3.16% | ✗ | $220.6K |
| Feb 10, 2026 | Feb 12, 2026 | Garnett Timothy John | Director | Buy | 97.5 | +14,124 | 28.52% | ✗ | $252.7K |
| Feb 10, 2026 | Feb 12, 2026 | Malenka Robert C. | Director | Sell | 22.5 | -6,863 | -1.76% | ✗ | $124.3K |
| Feb 5, 2026 | Feb 9, 2026 | GILLIS JONATHAN | CAAO and PAO | Neutral | 77.5 | +6,020 | 2.42% | ✗ | - |
| Feb 5, 2026 | Feb 9, 2026 | Setia Vishwas | CFO | Neutral | 77.5 | +7,730 | 1.99% | ✗ | - |
| Feb 5, 2026 | Feb 9, 2026 | Lillie James Woodruff | Chief Scientific Officer | Neutral | 82.5 | +7,730 | 2.66% | ✗ | - |
| Feb 5, 2026 | Feb 9, 2026 | Kreitzer Anatol | Chief Discovery Officer | Neutral | 77.5 | +6,020 | 2.37% | ✗ | - |
| Feb 5, 2026 | Feb 9, 2026 | Hanson Kristopher | General Counsel | Neutral | 82.5 | +7,730 | 4.20% | ✗ | - |
| Feb 5, 2026 | Feb 9, 2026 | Foff Erin Pennock | Chief Medical Officer | Neutral | 82.5 | +13,360 | 3.42% | ✗ | - |
| Feb 5, 2026 | Feb 9, 2026 | Kroeger Christopher A. | CEO | Neutral | 77.5 | +23,145 | 1.34% | ✗ | - |
| Feb 2, 2026 | Feb 4, 2026 | Malenka Robert C. | Director | Sell | 22.5 | -7,040 | -1.77% | ✗ | $126.9K |
| Jan 28, 2026 | Jan 30, 2026 | Malenka Robert C. | Director | Sell | 20.0 | -34,398 | -7.97% | ✗ | $635.9K |
| Jan 27, 2026 | Jan 29, 2026 | Setia Vishwas | CFO | Sell | 40.0 | -33,382 | -7.93% | ✗ | $600.2K |
| Jan 27, 2026 | Jan 29, 2026 | Lillie James Woodruff | Chief Scientific Officer | Sell | 40.0 | -45,055 | -13.40% | ✗ | $810.1K |
| Jan 27, 2026 | Jan 29, 2026 | Kreitzer Anatol | Chief Discovery Officer | Sell | 40.0 | -42,099 | -14.22% | ✗ | $756.9K |
| Jan 27, 2026 | Jan 29, 2026 | GILLIS JONATHAN | CAAO and PAO | Sell | 40.0 | -22,050 | -8.15% | ✗ | $396.5K |
| Jan 27, 2026 | Jan 29, 2026 | Kroeger Christopher A. | CEO | Sell | 37.5 | -204,146 | -10.57% | ✗ | $3.7M |
| Jan 27, 2026 | Jan 29, 2026 | Foff Erin Pennock | Chief Medical Officer | Sell | 40.0 | -44,616 | -10.25% | ✗ | $802.2K |
| Jan 27, 2026 | Jan 29, 2026 | Hanson Kristopher | General Counsel | Sell | 40.0 | -26,007 | -12.39% | ✗ | $467.6K |
| Nov 18, 2025 | Pavlov George | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 28, 2025 | Oct 30, 2025 | Novo Holdings A/S | 10% Owner | Buy | 100.0 | +952,941 | 34.86% | ✗ | $16.2M |
| Oct 28, 2025 | Oct 29, 2025 | Catalyst4, Inc. | 10% Owner | Buy | 100.0 | +5,441,176 | 38.17% | ✗ | $92.5M |
| Oct 27, 2025 | Oct 28, 2025 | Garnett Timothy John | Director | Neutral | 90.0 | +6,294 | 100.00% | ✗ | - |
| Oct 27, 2025 | Oct 28, 2025 | Walker Maria C | Director | Neutral | 90.0 | +6,294 | 100.00% | ✗ | - |
| Oct 27, 2025 | Oct 28, 2025 | Hanson Kristopher | General Counsel | Neutral | 90.0 | +27,098 | 100.00% | ✗ | - |
| Oct 27, 2025 | Oct 28, 2025 | GILLIS JONATHAN | CAAO and PAO | Neutral | 90.0 | +30,565 | 100.00% | ✗ | - |
| Oct 27, 2025 | Oct 28, 2025 | Kreitzer Anatol | Chief Discovery Officer | Neutral | 90.0 | +35,953 | 100.00% | ✗ | - |
| Oct 27, 2025 | Oct 28, 2025 | Lillie James Woodruff | Chief Scientific Officer | Neutral | 90.0 | +32,539 | 100.00% | ✗ | - |
| Oct 27, 2025 | Oct 28, 2025 | Setia Vishwas | CFO | Neutral | 90.0 | +43,367 | 100.00% | ✗ | - |
| Oct 27, 2025 | Oct 28, 2025 | Foff Erin Pennock | Chief Medical Officer | Neutral | 90.0 | +48,275 | 100.00% | ✗ | - |
| Oct 27, 2025 | Oct 28, 2025 | Malenka Robert C. | Director | Neutral | 85.0 | +34,390 | 9.41% | ✗ | - |
| Oct 27, 2025 | Oct 28, 2025 | Kroeger Christopher A. | CEO | Neutral | 90.0 | +225,693 | 223.04% | ✗ | - |
| Oct 27, 2025 | Catalyst4, Inc. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Novo Holdings A/S | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Trenkle James D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Pavlov George | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Luneborg Nanna Liebach | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Hanson Kristopher | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Kreitzer Anatol | Chief Discovery Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Foff Erin Pennock | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Garnett Timothy John | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Lillie James Woodruff | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Setia Vishwas | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | GILLIS JONATHAN | CAAO and PAO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Walker Maria C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Kroeger Christopher A. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2025 | Malenka Robert C. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |